The cagrilintide and retatrutide metabolic outcomes study raises an important research question: could two investigational approaches to metabolic regulation offer complementary effects? But understanding the evidence starts with a distinction that should not get lost in headlines. The combination study published in Nature Metabolism was preclinical research conducted in obese…
-
-
Cagrilintide is an investigational peptide medicine being studied for weight management and metabolic health. It belongs to a group of medicines known as amylin analogues, which are designed to imitate some of the effects of the naturally occurring hormone amylin. Research so far suggests that cagrilintide may help reduce appetite,…
-
What Is Cagrilintide? Cagrilintide is an investigational long-acting amylin analogue being studied for weight management and type 2 diabetes. Amylin is a hormone released by the pancreas after eating. It helps regulate appetite, slows the movement of food from the stomach, and supports blood-glucose control. Unlike approved medicines such as…